My Mother Had Alzheimer’s. That’s Why I Started a GLP-1
As an endocrinologist, I spend much of my day discussing GLP-1 medications with my patients. This week, I…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
When GLP-1s Change Patients’ Libido: What to Know
It’s not discussed as often as other side effects of GLP-1 receptor agonists, but one adverse effect is…
Pricey Drugs Unlikely to Solve Dementia
This transcript has been edited for clarity. Dear colleagues, I’m Christoph Diener from the faculty of medicine at…
Most GLP-1 Prescriptions Miss the Mark: Are Yours?
GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…